内分泌学
内科学
胰岛素抵抗
罗格列酮
胰岛素
过氧化物酶体增殖物激活受体
棕榈酸
肾
胰岛素降解酶
生物
化学
脂肪酸
受体
医学
生物化学
作者
Qian Su,Juan Huang,Xi Chen,Yijie Wang,Muqing Shao,Hongjia Yan,Caiyu Chen,Hongmei Ren,Fuwei Zhang,Yinxing Ni,Pedro A. José,Jian Zhong,Jian Yang
标识
DOI:10.1002/mnfr.202200589
摘要
Long-term high-fat diet (HFD) causes insulin resistance, which is a primary etiological factor in the development of obesity and type 2 diabetes mellitus. Impaired insulin clearance is not only a consequence but also a cause of insulin resistance. The kidney is a major site of insulin clearance, where the insulin-degrading enzyme (IDE) plays a vital role in the proximal tubule. Thus, the study investigates the role of renal IDE in the regulation of insulin resistance in HFD-induced obese mice.Twenty four-weeks of HFD in C57BL/6 mice causes insulin resistance and impaires insulin clearance, accompanied by a decrease in renal IDE expression and activity. Palmitic acid decreases IDE mRNA and protein expressions in HK-2 cells. RNA-Seq analysis found that the PPAR pathway is involved. 24-weeks of HFD decreases renal PPARγ, but not PPARα or PPARβ/δ mRNA expression. The inhibition of IDE expression by palmitic acid is prevented by the PPARγ agonist rosiglitazone. The amount of PPARγ bound to the promoters of IDE is decreased in palmitic acid-treated cells. Rosiglitazone improves insulin clearance and insulin resistance and increases renal IDE expression in HFD fed-mice.Long-term HFD decreases renal IDE expression and activity, and causes insulin resistance, which involves PPARγ.
科研通智能强力驱动
Strongly Powered by AbleSci AI